1887

Abstract

Sepsis, a systemic, deleterious host response to infection that leads to organ dysfunction, is a potentially deadly condition needing prompt identification of the causative organisms and early appropriate antimicrobial therapy. Among non-culture-based diagnostic methods, Septi (SF) can be employed to speed bacterial and fungal DNA detection, but it suffers from poor sensitivity and high cost. The aim of the present study, performed in 285 febrile patients, was to develop a prediction model to restrict the SF assay to clinical cases with a high probability of positive SF results. The prevalence of SF results positive for a pathogen was 17.2 %. Independent predictors of positive results were: blood sampling within 12 h after the onset of fever [odds ratio (OR) 20.03; 95 % confidence interval (CI) 6.87–58.38; <0.0001]; ≥0.5 ng serum procalcitonin (PCT) ml (OR 18.52; 95 % CI 5.12–67.02; <0.0001); body temperature ≥38 °C (OR 3.78; 95 % CI 1.39–10.25;  = 0.009); ≤3 g serum albumin dl (OR 3.40; 95 % CI 1.27–9.08;  = 0.014); and ≥13 000 white blood cells mm (OR 2.75; 95 % CI 1.09–7.69;  = 0.05). The model showed good calibration (Hosmer–Lemeshow chi-squared 1.61;  = 0.978). Area under the receiving operating characteristic curve was 0.944 (95 % CI 0.914–0.973; <0.0001). These results suggest that a prediction model based on PCT and a few other routinely available laboratory and clinical variables could be of help in selecting patients with a high probability of SF-positive results.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.064097-0
2014-05-01
2024-03-19
Loading full text...

Full text loading...

/deliver/fulltext/jmm/63/5/649.html?itemId=/content/journal/jmm/10.1099/jmm.0.064097-0&mimeType=html&fmt=ahah

References

  1. Bauer M., Reinhart K. 2010; Molecular diagnostics of sepsis – where are we today?. Int J Med Microbiol 300:411–413 [View Article][PubMed]
    [Google Scholar]
  2. Bennett I. L. Jr 1954; The significance of fever in infections. Yale J Biol Med 26:491–505[PubMed]
    [Google Scholar]
  3. Bennett I. L. Jr, Beeson P. B. 1954; Bacteremia: a consideration of some experimental and clinical aspects. Yale J Biol Med 26:241–262[PubMed]
    [Google Scholar]
  4. Bone R. C., Balk R. A., Cerra F. B., Dellinger R. P., Fein A. M., Knaus W. A., Schein R. M., Sibbald W. J. 2009; Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 136:Suppl.e28[PubMed] [CrossRef]
    [Google Scholar]
  5. Bossink A. W., Groeneveld A. B., Hack C. E., Thijs L. G. 1999; The clinical host response to microbial infection in medical patients with fever. Chest 116:380–390 [View Article][PubMed]
    [Google Scholar]
  6. Casalta J. P., Gouriet F., Roux V., Thuny F., Habib G., Raoult D. 2009; Evaluation of the LightCycler SeptiFast test in the rapid etiologic diagnostic of infectious endocarditis. Eur J Clin Microbiol Infect Dis 28:569–573 [View Article][PubMed]
    [Google Scholar]
  7. Chang S. S., Hsieh W. H., Liu T. S., Lee S. H., Wang C. H., Chou H. C., Yeo Y. H., Tseng C. P., Lee C. C. 2013; Multiplex PCR system for rapid detection of pathogens in patients with presumed sepsis – a systemic review and meta-analysis. PLoS ONE 8:e62323 [View Article][PubMed]
    [Google Scholar]
  8. Chiesa C., Panero A., Rossi N., Stegagno M., De Giusti M., Osborn J. F., Pacifico L. 1998; Reliability of procalcitonin concentrations for the diagnosis of sepsis in critically ill neonates. Clin Infect Dis 26:664–672 [View Article][PubMed]
    [Google Scholar]
  9. Christ-Crain M., Müller B. 2005; Procalcitonin in bacterial infections – hype, hope, more or less?. Swiss Med Wkly 135:451–460[PubMed]
    [Google Scholar]
  10. Clemmer T. P., Fisher C. J. Jr, Bone R. C., Slotman G. J., Metz C. A., Thomas F. O. the Methylprednisolone Severe Sepsis Study Group 1992; Hypothermia in the sepsis syndrome and clinical outcome. Crit Care Med 20:1395–1401 [View Article][PubMed]
    [Google Scholar]
  11. Dellinger R. P., Levy M. M., Rhodes A., Annane D., Gerlach H., Opal S. M., Sevransky J. E., Sprung C. L., Douglas I. S. other authors 2013; Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 41:580–637 [View Article][PubMed]
    [Google Scholar]
  12. Dierkes C., Ehrenstein B., Siebig S., Linde H. J., Reischl U., Salzberger B. 2009; Clinical impact of a commercially available multiplex PCR system for rapid detection of pathogens in patients with presumed sepsis. BMC Infect Dis 9:126 [View Article][PubMed]
    [Google Scholar]
  13. Dombrovskiy V. Y., Martin A. A., Sunderram J., Paz H. L. 2007; Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003. Crit Care Med 35:1244–1250 [View Article][PubMed]
    [Google Scholar]
  14. Domínguez de Villota E., Mosquera J. M., Rubio J. J., Galdos P., Díez Balda V., de la Serna J. L., Tomás M. I. 1980; Association of a low serum albumin with infection and increased mortality in critically ill patients. Intensive Care Med 7:19–22 [View Article][PubMed]
    [Google Scholar]
  15. Falguera M., Trujillano J., Caro S., Menéndez R., Carratalà J., Ruiz-González A., Vilà M., García M., Porcel J. M., Torres A. the NAC-CALIDAD (Proyecto Integrado de Investigación de la Sociedad Española de Patología del Aparato Respiratorio sobre Infecciones Respiratorias de Vías Bajas) Study Group 2009; A prediction rule for estimating the risk of bacteremia in patients with community-acquired pneumonia. Clin Infect Dis 49:409–416 [View Article][PubMed]
    [Google Scholar]
  16. Goldwasser P., Feldman J. 1997; Association of serum albumin and mortality risk. J Clin Epidemiol 50:693–703 [View Article][PubMed]
    [Google Scholar]
  17. Jaimes F., Arango C., Ruiz G., Cuervo J., Botero J., Vélez G., Upegui N., Machado F. 2004; Predicting bacteremia at the bedside. Clin Infect Dis 38:357–362 [View Article][PubMed]
    [Google Scholar]
  18. Kasper D. C., Altiok I., Mechtler T. P., Böhm J., Straub J., Langgartner M., Pollak A., Herkner K. R., Berger A. 2013; Molecular detection of late-onset neonatal sepsis in premature infants using small blood volumes: proof-of-concept. Neonatology 103:268–273 [View Article][PubMed]
    [Google Scholar]
  19. Lee C. C., Wu C. J., Chi C. H., Lee N. Y., Chen P. L., Lee H. C., Chang C. M., Ko N. Y., Ko W. C. 2012; Prediction of community-onset bacteremia among febrile adults visiting an emergency department: rigor matters. Diagn Microbiol Infect Dis 73:168–173 [View Article][PubMed]
    [Google Scholar]
  20. Lehmann L. E., Hunfeld K. P., Emrich T., Haberhausen G., Wissing H., Hoeft A., Stüber F. 2008; A multiplex real-time PCR assay for rapid detection and differentiation of 25 bacterial and fungal pathogens from whole blood samples. Med Microbiol Immunol (Berl) 197:313–324 [View Article][PubMed]
    [Google Scholar]
  21. Lehmann L. E., Hunfeld K. P., Steinbrucker M., Brade V., Book M., Seifert H., Bingold T., Hoeft A., Wissing H., Stüber F. 2010; Improved detection of blood stream pathogens by real-time PCR in severe sepsis. Intensive Care Med 36:49–56 [View Article][PubMed]
    [Google Scholar]
  22. Lucignano B., Ranno S., Liesenfeld O., Pizzorno B., Putignani L., Bernaschi P., Menichella D. 2011; Multiplex PCR allows rapid and accurate diagnosis of bloodstream infections in newborns and children with suspected sepsis. J Clin Microbiol 49:2252–2258 [View Article][PubMed]
    [Google Scholar]
  23. Luzzani A., Polati E., Dorizzi R., Rungatscher A., Pavan R., Merlini A. 2003; Comparison of procalcitonin and C-reactive protein as markers of sepsis. Crit Care Med 31:1737–1741 [View Article][PubMed]
    [Google Scholar]
  24. Martin G. S., Mannino D. M., Eaton S., Moss M. 2003; The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348:1546–1554 [View Article][PubMed]
    [Google Scholar]
  25. Mauro M. V., Cavalcanti P., Perugini D., Noto A., Sperlì D., Giraldi C. 2012; Diagnostic utility of LightCycler SeptiFast and procalcitonin assays in the diagnosis of bloodstream infection in immunocompromised patients. Diagn Microbiol Infect Dis 73:308–311 [View Article][PubMed]
    [Google Scholar]
  26. Mencacci A., Leli C., Cardaccia A., Meucci M., Moretti A., D’Alò F., Farinelli S., Pagliochini R., Barcaccia M., Bistoni F. 2012a; Procalcitonin predicts real-time PCR results in blood samples from patients with suspected sepsis. PLoS ONE 7:e53279 [View Article][PubMed]
    [Google Scholar]
  27. Mencacci A., Leli C., Montagna P., Cardaccia A., Meucci M., Bietolini C., Cenci E., Pasticci M. B., Bistoni F. 2012b; Diagnosis of infective endocarditis: comparison of the LightCycler SeptiFast real-time PCR with blood culture. J Med Microbiol 61:881–883 [View Article][PubMed]
    [Google Scholar]
  28. Navarro E., Segura J. C., Castaño M. J., Solera J. 2006; Use of real-time quantitative polymerase chain reaction to monitor the evolution of Brucella melitensis DNA load during therapy and post-therapy follow-up in patients with brucellosis. Clin Infect Dis 42:1266–1273 [View Article][PubMed]
    [Google Scholar]
  29. Navasa M., Rodés J. 2004; Bacterial infections in cirrhosis. Liver Int 24:277–280 [View Article][PubMed]
    [Google Scholar]
  30. Øvstebø R., Brandtzaeg P., Brusletto B., Haug K. B., Lande K., Høiby E. A., Kierulf P. 2004; Use of robotized DNA isolation and real-time PCR to quantify and identify close correlation between levels of Neisseria meningitidis DNA and lipopolysaccharides in plasma and cerebrospinal fluid from patients with systemic meningococcal disease. J Clin Microbiol 42:2980–2987 [View Article][PubMed]
    [Google Scholar]
  31. Paolucci M., Stanzani M., Melchionda F., Tolomelli G., Castellani G., Landini M. P., Varani S., Lewis R. E., Sambri V. 2013; Routine use of a real-time polymerase chain reaction method for detection of bloodstream infections in neutropaenic patients. Diagn Microbiol Infect Dis 75:130–134 [View Article][PubMed]
    [Google Scholar]
  32. Pasqualini L., Mencacci A., Leli C., Montagna P., Cardaccia A., Cenci E., Montecarlo I., Pirro M., di Filippo F. other authors 2012; Diagnostic performance of a multiple real-time PCR assay in patients with suspected sepsis hospitalized in an internal medicine ward. J Clin Microbiol 50:1285–1288 [View Article][PubMed]
    [Google Scholar]
  33. Peters R. P., van Agtmael M. A., Gierveld S., Danner S. A., Groeneveld A. B., Vandenbroucke-Grauls C. M., Savelkoul P. H. 2007; Quantitative detection of Staphylococcus aureus and Enterococcus faecalis DNA in blood to diagnose bacteremia in patients in the intensive care unit. J Clin Microbiol 45:3641–3646 [View Article][PubMed]
    [Google Scholar]
  34. Riedel S. 2012; Procalcitonin and the role of biomarkers in the diagnosis and management of sepsis. Diagn Microbiol Infect Dis 73:221–227 [View Article][PubMed]
    [Google Scholar]
  35. Riedel S., Bourbeau P., Swartz B., Brecher S., Carroll K. C., Stamper P. D., Dunne W. M., McCardle T., Walk N. other authors 2008; Timing of specimen collection for blood cultures from febrile patients with bacteremia. J Clin Microbiol 46:1381–1385 [View Article][PubMed]
    [Google Scholar]
  36. Riedel S., Melendez J. H., An A. T., Rosenbaum J. E., Zenilman J. M. 2011; Procalcitonin as a marker for the detection of bacteremia and sepsis in the emergency department. Am J Clin Pathol 135:182–189 [View Article][PubMed]
    [Google Scholar]
  37. Schuetz P., Albrich W., Mueller B. 2011; Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future. BMC Med 9:107 [View Article][PubMed]
    [Google Scholar]
  38. Shapiro N. I., Wolfe R. E., Wright S. B., Moore R., Bates D. W. 2008; Who needs a blood culture? A prospectively derived and validated prediction rule. J Emerg Med 35:255–264 [View Article][PubMed]
    [Google Scholar]
  39. Simon L., Gauvin F., Amre D. K., Saint-Louis P., Lacroix J. 2004; Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis 39:206–217 [View Article][PubMed]
    [Google Scholar]
  40. Steyerberg E. W., Harrell F. E. Jr, Borsboom G. J. J. M., Eijkemans M. J. C., Vergouwe Y., Habbema J. D. F. 2001; Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. J Clin Epidemiol 54:774–781 [View Article][PubMed]
    [Google Scholar]
  41. Varani S., Stanzani M., Paolucci M., Melchionda F., Castellani G., Nardi L., Landini M. P., Baccarani M., Pession A., Sambri V. 2009; Diagnosis of bloodstream infections in immunocompromised patients by real-time PCR. J Infect 58:346–351 [View Article][PubMed]
    [Google Scholar]
  42. Versalovic J., Carroll K. C., Funke G., Jorgensen J. H., Landry M. L., Warnock D. W. 2011 Manual of Clinical Microbiology, 10th edn. Washington, DC: American Society for Microbiology;
    [Google Scholar]
  43. Vince A., Lepej S. Z., Barsić B., Dusek D., Mitrović Z., Serventi-Seiwerth R., Labar B. 2008; LightCycler SeptiFast assay as a tool for the rapid diagnosis of sepsis in patients during antimicrobial therapy. J Med Microbiol 57:1306–1307 [View Article][PubMed]
    [Google Scholar]
  44. Vincent J. L., Opal S. M., Marshall J. C., Tracey K. J. 2013; Sepsis definitions: time for change. Lancet 381:774–775 [View Article][PubMed]
    [Google Scholar]
  45. Weinstein M. P. 2003; Blood culture contamination: persisting problems and partial progress. J Clin Microbiol 41:2275–2278 [View Article][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.064097-0
Loading
/content/journal/jmm/10.1099/jmm.0.064097-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error